News

Category: DIAN-TU Announcement

Gantenerumab improved markers of disease in rare, inherited form of Alzheimer’s disease

Further analysis of data from an international trial of two investigational drugs in people in the early stages of a...

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - FEB 10 2020

Major Alzheimer’s study to open 5 new Latin American sites

Washington University School of Medicine news release - Nov 20 2019

Update on the DIAN-TU-001 TRIAL

Update on the DIAN-TU-001 TRIAL:  Janssen BACE Inhibitor (JNJ-54861911/atabecestat) DRUG ARM DISCONTINUATION The statement below is an update to the...

DIAN-TU Trial Interim Analysis

Notice to DIAN-TU Investigational Sites and Participants RE: DIAN-TU-001 INTERIM ANALYSIS April 25, 2018 DIAN-TU Site Leaders and Participants, The...

Important announcement from the DIAN-TU regarding Janssen BACE inhibitor

Janssen website

DIAN-TU’s Alzheimer’s prevention trial opens enrollment to third drug

DIAN-TU open enrollment announcement